| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |